Current Affairs - Science - Discussion

Discussion Forum : Science - Latest Current Affairs (Q.No. 84)

2024-02-09 Science

84.

Which company's vaccine demonstrated long-term efficacy in a phase-3 trial conducted in Malawi, Africa, a region endemic for typhoid fever?

Pfizer

Bharat Biotech

Moderna

AstraZeneca

Answer: Option

Explanation:

Bharat Biotech's Typhoid conjugate vaccine (TCV), Typbar, was proven efficacious in a phase-3 trial conducted in Malawi, Africa, a region known for its high incidence of typhoid fever. This vaccine is recognized as the world's first clinically proven conjugate Typhoid vaccine.